Bausch Health Companies | VRX - Sales Revenues

Stock Price
8.20
Daily Change
-0.17 -2.03%
Monthly
5.26%
Yearly
-25.72%
Q1 Forecast
8.16

Bausch Health Companies reported $2.8B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Amgen USD 9.9B 340M Dec/2025
ANI Pharmaceuticals USD 227.81M 16.44M Sep/2025
Aurora Cannabis CAD 90.37M 7.65M Sep/2025
Bausch Health Companies USD 2.8B 120M Dec/2025
Biogen USD 2.28B 250M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Canopy Growth CAD 66.68M 5.45M Sep/2025
Corcept Therapeutics USD 202.12M 5.48M Dec/2025
Danaher USD 6.84B 790M Dec/2025
Drreddys Laboratories INR 87.27B 1.82B Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
Nektar Therapeutics USD 24.12M 635K Sep/2024
Novo Nordisk DKK 79.14B 4.16B Dec/2025
Pacira USD 179.52M 1.58M Sep/2025
Perrigo USD 1.04B 16.3M Sep/2025
Phibro Animal Health USD 309.26M 48.83M Dec/2024
Prestige Brands USD 283.44M 9.34M Dec/2025
Supernus Pharmaceuticals USD 211.6M 19.5M Dec/2025
Vertex Pharmaceuticals USD 3.19B 110M Dec/2025
Zoetis USD 2.4B 0 Dec/2025